Oppenheimer & CO Inc Beyond Air, Inc. Transaction History
Oppenheimer & CO Inc
- $5.91 Billion
- Q1 2024
A detailed history of Oppenheimer & CO Inc transactions in Beyond Air, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 19,200 shares of XAIR stock, worth $10,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,200
Previous 21,200
9.43%
Holding current value
$10,368
Previous $41,000
19.51%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XAIR
# of Institutions
70Shares Held
15.8MCall Options Held
48.7KPut Options Held
27.2K-
Aigh Capital Management LLC Baltimore, MD3.71MShares$2.01 Million2.6% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$975,8960.0% of portfolio
-
Gendell Jeffrey L Greenwich, CT1.46MShares$788,9780.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$755,6200.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.36MShares$733,4080.29% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $16.1M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...